Latest News

  • Sema4 Begins Trading, Eyes Healthcare Partnerships, Liquid Biopsy

    Diagnostics World News | The board members of both Sema4 and CM Life Sciences voted this week to approve the special purpose acquisition company. The resulting combined company, Sema4 Holdings Corp, will commence trading of its shares of common stock and warrants on the Nasdaq Global Select Market under the ticker symbols "SMFR" and “SMFRW” today or Monday.

    Jul 23, 2021
  • PacBio Acquires Short-Read Sequencer Omniome for $800M

    Diagnostics World News | Pacific Biosciences announced this morning that it has signed a definitive merger agreement under which it will acquire Omniome, a San Diego-based company developing a highly differentiated, proprietary short-read sequencing platform capable of delivering high accuracy.

    Jul 20, 2021
  • Inflammatory Clock Measures ‘Universal’ Hallmark Of Aging

    Diagnostics World News | Systemic chronic inflammation—a universally strong signal of ill health associated with all nine hallmarks of aging and diseases that collectively represent the leading causes of disability and mortality worldwide—can now be measured by an inflammatory clock of aging (iAge) developed by investigators at the Stanford University School of Medicine and the Buck Institute for Research on Aging. It is the first “actionable clock” that predicts multimorbidity, frailty, immunological health, and chronic diseases of aging.

    Jul 15, 2021
  • COVID-19 Diagnostics Commons Looks to Democratize Knowledge, Help Employers Address Challenges of Bringing Workers Back

    Diagnostics World News | Employers are testing for COVID-19 at noticeably higher levels in 2021 compared to late 2020, according to findings from a global business survey conducted by Arizona State University's College of Health Solutions and the World Economic Forum, along with support from the Rockefeller Foundation. Responses came from over 1,100 companies spanning more than 20 industry sectors and over 30 countries.

    Jul 13, 2021
  • A Glimpse Into the Future Of Infectious Disease Diagnostics

    Diagnostics World News | A “silver lining” of COVID-19 is that it has ushered in a new era of diagnostic innovation within test manufacturing facilities and clinical and public health laboratories, producing in 18 months what would be a decade’s worth of progress in non-pandemic times. Near-universal focus on one common problem created new ways to work together, overcome gaps in resources, and develop novel point-of-care testing methods under intense time pressures, as will be explored during the upcoming Next-Gen Dx Summit.

    Jul 8, 2021
  • Brain Age Prediction Model Distinguishes Normal Cognitive Impairment From Early AD

    Diagnostics World News | A team of researchers from Beijing Normal University in China has developed an artificial intelligence-based brain age prediction model to quantify deviations from a healthy brain-aging trajectory in patients with mild cognitive impairment. They hope the model will help earlier detection of cognitive impairment at an individual level.

    Jul 6, 2021
  • Follow the Money: Microbiome-Based Diagnostics

    Diagnostics World News | Insilico Medicine closes a Series C for AI-powered drug discovery, while other investments fuel microbiome-based diagnostics.

    Jul 2, 2021
  • New Diagnostic Partnerships, Products, and COVID-19 Testing Updates

    Diagnostics World News | What’s next for Biogen and Eisai; COVID updates from Thermo Fisher, New England Biolabs, and OraSure; new products from QIAGEN, InterVenn, Nuvo Group and more.

    Jun 29, 2021
  • White-Box Algorithms Could Invite More EEG-Based Monitoring In The OR

    Diagnostics World News | Only about a quarter of anesthesiologists delivering anesthesia to patients during surgery are monitoring unconsciousness using electroencephalography (EEG), the recording of neural activity via electrodes on the scalp. A new company spun out of MIT and MGH hopes to change that.

    Jun 23, 2021
  • Mayo May Soon Bring AI-Enabled Electrocardiograms To The Clinic

    Diagnostics World News | Researchers at the Mayo Clinic have demonstrated that a standard, 12-lead electrocardiogram (ECG)—supplemented with AI—can be a biomarker of biological age, and the gap relative to chronological age is an independent risk predictor of both all-cause and cardiovascular mortality. Artificial intelligence (AI) was used to predict biological age from ECGs.

    Jun 21, 2021
  • Miniaturized Ultrasound Technology: Taking Advantage of Accessibility, Not Compromising Quality of Care

    Diagnostics World News | Much like other technology devices, medical equipment is getting smaller. Ultrasound machines, for example, are no longer forced to live on carts that are pushed from examination room to examination room. Many can now fit in the palm of your hand and operate through Smart Phones. While the machines no longer have the same complex look and feel, training health care professionals, who will be using these devices, correctly and accurately is absolutely paramount to quality patient care.

    Jun 18, 2021
  • Gamifying Vision: How Mobile Gaming Is Tracking Vision Degradation in Patients

    Diagnostics World News | Tilak Healthcare aims to combine video games with medical expertise so that the same vision monitoring tools that are reliable and useful for doctors will be playful and fun for users. If Tilak can achieve that, the company tools will be “sticky” enough to have a longstanding impact on the healthcare process for patients.

    Jun 15, 2021
  • AI Algorithms Match Pathologists In Quantifying Tumor Cellularity

    Diagnostics World News | Artificial intelligence (AI) algorithms were recently found to perform on par with pathologists when it came to quantifying tumor cellularity, an increasingly common measure of patient response to neoadjuvant therapy for breast cancer. That was one of the key findings of the Breast Pathology Quantitative Biomarkers (BreastPathQ) Challenge.

    Jun 9, 2021
  • NIH, CDC Public Health Initiative Examines Impact of At-Home COVID-19 Testing

    Diagnostics World News | A new public health initiative is looking to determine whether widespread access to rapid at-home antigen tests can help reduce the spread of SARS-CoV-2, the virus that causes COVID-19. Dubbed “Say Yes! COVID Test,” the initiative launched by the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) is zeroing in on Pitt County, N.C., and Chattanooga/Hamilton County, Tenn.

    Jun 7, 2021
  • Diagnostics Funding for Infectious Diseases, Applied NGS: Follow the Money

    Diagnostics World News | NGS turnkey diagnostics, noninvasive prenatal testing with simplified sample collection, infection disease diagnostics, and more.

    Jun 3, 2021
  • New COVID Diagnostics, Pandemic Sciences Centre Launches, New Products

    Diagnostics World News | University of Oxford launches a new Pandemic Sciences Centre, Quest Diagnostics and Paige collaborate on AI for diagnostics, new products from Waters and Essenlix Corp, and COVID updates from Advanced Biological Laboratories, Ortho Clinical Diagnostics, Thermo Fisher.

    Jun 1, 2021
  • Synthetic Data Helps AI Train To Classify Brain Tumors

    Diagnostics World News | Over the past year, Michigan Medicine and Synthetaic have been collaborating to generate synthetic data to improve the rate at which brain tumors get accurately diagnosed intraoperatively. The initiative involves using a generative adversarial network to “grow" data since large public repositories do not contain the kind of images needed to guide real-time decision-making about which surgery is best for patients.

    May 27, 2021
  • Diagnostic Host Response Tests Digging Deeper For Answers

    Diagnostics World News | Today the term “presymptomatic” is thrown into casual conversations around the dinner table, and large diagnostic companies are interested in producing products providing presymptomatic notice of infection with a pathogen. In fact, new host response bacterial-viral (HR-B/V) tests that could offer an early warning system for infections.

    May 26, 2021
  • Advanced High-End Microbiological Incubators: Protecting Test Samples, Laboratory Personnel and Public Health during the COVID-19 Pandemic

    Diagnostics World News | Diagnostic testing continues to play a vital role in protecting public health throughout the COVID-19 pandemic. However, we should not overlook the importance of using workflows that safeguard the health of medical laboratory personnel by preventing potential exposure to the SARS-CoV-2 virus. This is of utmost significance given the high volume of tests processed every day, increasing the risk to laboratory teams.

    May 24, 2021
  • New Medication Insight Reports for 23andMe+ Members On Depression Drug, Blood Thinner

    Diagnostics World News | 23andMe released two new medication insight reports last week as part of the company’s 23andMe+ membership. The two new reports provide medication insights on how a person’s CYP2C19 metabolizer profile may impact therapies with citalopram, a blood thinner, and clopidogrel, an antidepressant.

    May 20, 2021